Venous thromboembolism: Why is it still a significant health problem?
M Oleksiuk-Bojko, A Lisowska - Advances in Medical Sciences, 2023 - Elsevier
Background Venous thromboembolism (VTE) remains the third leading cause of acute
cardiovascular syndrome following myocardial infarction and ischemic stroke. The global …
cardiovascular syndrome following myocardial infarction and ischemic stroke. The global …
Direct oral anticoagulant therapy in patients with morbid obesity after intermediate-or high-risk pulmonary emboli
DJ Lachant, C Bach, A Fe, RJ White… - ERJ open …, 2021 - Eur Respiratory Soc
There is little reported on the efficacy and safety of direct oral anticoagulants (DOACs) in
morbid obesity after venous thromboembolism (VTE). In this observational study, patients …
morbid obesity after venous thromboembolism (VTE). In this observational study, patients …
Commentary: what we might or might not know about venous thromboembolism prophylaxis in neurosurgery
SJ Haines - Neurosurgery, 2020 - journals.lww.com
Commentary: What We Might or Might Not Know About Venous Thr... : Neurosurgery
Commentary: What We Might or Might Not Know About Venous Thromboembolism Prophylaxis …
Commentary: What We Might or Might Not Know About Venous Thromboembolism Prophylaxis …